Larson Financial Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.8M | Buy |
63,337
+8,781
| +16% | +$943K | 0.27% | 84 |
|
|
2025
Q1 | $5.5M | Buy |
54,556
+2,147
| +4% | +$217K | 0.26% | 76 |
|
|
2024
Q4 | $4.68M | Buy |
52,409
+4,599
| +10% | +$411K | 0.24% | 83 |
|
|
2024
Q3 | $4.01M | Buy |
47,810
+1,710
| +4% | +$143K | 0.23% | 89 |
|
|
2024
Q2 | $3.55M | Buy |
46,100
+1,517
| +3% | +$117K | 0.24% | 76 |
|
|
2024
Q1 | $3.05M | Sell |
44,583
-1,036
| -2% | -$71K | 0.24% | 81 |
|
|
2023
Q4 | $2.64M | Sell |
45,619
-390
| -0.8% | -$22.5K | 0.23% | 80 |
|
|
2023
Q3 | $2.43M | Buy |
46,009
+1,450
| +3% | +$76.6K | 0.24% | 78 |
|
|
2023
Q2 | $2.41M | Sell |
44,559
-523
| -1% | -$28.3K | 0.24% | 79 |
|
|
2023
Q1 | $2.26M | Buy |
45,082
+1,265
| +3% | +$63.3K | 0.25% | 83 |
|
|
2022
Q4 | $2.03M | Buy |
43,817
+94
| +0.2% | +$4.35K | 0.24% | 84 |
|
|
2022
Q3 | $1.69M | Buy |
43,723
+42,492
| +3,452% | +$1.65M | 0.24% | 73 |
|
|
2022
Q2 | $46K | Buy |
1,231
+616
| +100% | +$23K | 0.01% | 385 |
|
|
2022
Q1 | $27K | Buy |
615
+227
| +59% | +$9.97K | ﹤0.01% | 476 |
|
|
2021
Q4 | $16K | Hold |
388
| – | – | ﹤0.01% | 589 |
|
|
2021
Q3 | $17K | Hold |
388
| – | – | ﹤0.01% | 495 |
|
|
2021
Q2 | $17K | Hold |
388
| – | – | ﹤0.01% | 461 |
|
|
2021
Q1 | $15K | Hold |
388
| – | – | ﹤0.01% | 461 |
|
|
2020
Q4 | $14K | Hold |
388
| – | – | ﹤0.01% | 431 |
|
|
2020
Q3 | $15K | Hold |
388
| – | – | 0.01% | 369 |
|
|
2020
Q2 | $14K | Hold |
388
| – | – | 0.01% | 326 |
|
|
2020
Q1 | $13K | Hold |
388
| – | – | 0.01% | 259 |
|
|
2019
Q4 | $18K | Hold |
388
| – | – | 0.01% | 230 |
|
|
2019
Q3 | $16K | Hold |
388
| – | – | 0.01% | 245 |
|
|
2019
Q2 | $17K | Hold |
388
| – | – | 0.01% | 200 |
|
|
2019
Q1 | $15K | Hold |
388
| – | – | 0.01% | 197 |
|
|
2018
Q4 | $14K | Buy |
+388
| New | +$14K | 0.01% | 189 |
|